SavedAdd your journal

Journals / Haydarpaşa Numune Eğitim ve Araştırma Hastanesi Tıp Dergisi / 2013 / Cilt: 53 - Sayı: 3

NEW STRATEGIES IN LUNG CANCER IMMUNOTHERAPY

AKCİĞER KANSER İMMÜNOTERAPİSİNDE YENİ STRATEJİLER

Gülbu Aydınoğlu IŞITMANGİL
Pages
168–177
Publication Date
2022-10-17
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Despite aggressive treatment with surgery, radiation and chemotherapy, the long-term survival for lung cancer patients remains low which underscored the need to develop new therapeutic strategies like anti-tumor immunotherapy.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Lung cancer is the leading cause of cancer mortality.
📊
Key Findings & Data:Lung cancer is the leading cause of cancer mortality.
💡
Conclusion & Impact:Despite aggressive treatment with surgery, radiation and chemotherapy, the long-term survival for lung cancer patients remains low which underscored the need to develop new therapeutic strategies like anti-tumor immunotherapy.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Lung cancer is the leading cause of cancer mortality. Despite aggressive treatment with surgery, radiation and chemotherapy, the long-term survival for lung cancer patients remains low which underscored the need to develop new therapeutic strategies like anti-tumor immunotherapy.

Özet

Akciğer kanseri, kanser mortalitesinin başlıca sebebidir. Cerrahi, radyoterapi ve kemoterapi ile agresif tedavi yapılsa bile uzun sürvi elde etme şansı az olduğu için tümör karşıtı immünoterapi gibi yeni terapötik stratejiler geliştirme ihtiyacı doğmuştur.

🔖

Cite This Article

IŞITMANGİL, G. A. (2022). NEW STRATEGIES IN LUNG CANCER IMMUNOTHERAPY. Haydarpaşa Numune Eğitim ve Araştırma Hastanesi Tıp Dergisi, Cilt: 53 - Sayı: 3, 168–177. https://ajindex.com/articles/535387

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (6)

  1. Işıtmangil G, Işıtmangil T. Akciğer kanserinde immünoterapi. Aktüel Tıp Dergisi, Cilt 5(11): 7-10, 2000
  2. Rüttinger D, Hatz R, Jauch KW, Fox BA. Novel Strategies for Lung Cancer Immunotherapy. In (Eds: Shields, MD, Thomas W.; LoCicero, Joseph; Reed, Carolyn E.; Feins, Richard H.). General Thoracic Surgery, 7th Ed; 2009 Lippincott Williams & Wilkins
  3. Raez LE, MD; Fein S, Podack ER: Lung Cancer Immunotherapy. Clinical Medicine & Research. Volume 3, Number 4: 221-228, 2005
  4. Bradbury PA, Shepherd FA. Immunotherapy for Lung Cancer. Journal of Thoracic Oncology. 3(6):164-170. (Suppl. 2), 2008
  5. Leighl NB, Shepherd FA. Small Cell Lung Cancer. In Patterson GA, Cooper JD, Deslauriers J et al. (Eds): Pearson's Thoracic & Esophageal Surgery, 3rd Ed. Churchill Livingstone Elsevier, Philadelphia, PA, 2008, p: 825-840
  6. Gridelli C, Rossi A, Maione P, Ferrara L, Castaldo V, Sacco PC. Vaccines for the Treatment of Non-Small Cell Lung Cancer: A Renewed Anticancer Strategy. The Oncologist 2009; 14:909-920.